Products found to contain undeclared medicines
|
|
Singapore: Four ‘S Lion Juice’ products tested by HSA to contain erectile dysfunction drug and other potent chemicals |
|
Four products, labelled as ‘S Lion Juice’ and marketed to contain natural ingredients were tested by the Health Sciences Authority (HSA) and found to contain undeclared potent chemical ingredients, including tadalafil. HSA is warning members of the public not to consume these products as they may cause serious adverse effects, including loss of vision and hearing, strokes and heart attacks. They are sold through the Internet and have been touted to be ‘suitable for the entire family’. The four products are:
- S Lion Juice 10 gm: contains undeclared thiodimethylsildenafil and tadalafil;
- S Lion Juice 20 gm: contains undeclared thiodimethylsildenafil;
- S Lion Juice Orange 10 gm: contains undeclared propoxyphenyl thioaidenafil; and
- S Lion Juice 1: contains undeclared aminotadalafil and thiodimethylsildenafil
Thiodimethylsildenafil and propoxyphenyl thioaidenafil are chemically-related compounds of sildenafil; while aminotadalafil is related chemically to tadalafil. Sildenafil and tadalafil are potent prescription medicines. Both medicines are used to treat male erectile dysfunction and can potentially cause serious adverse effects such as decreased or loss of vision and hearing, low blood pressure, strokes, heart attacks and priapism (painful and exceedingly long erections) when used inappropriately. The adverse effects of the chemically-related compounds (thiodimethylsildenafil, propoxyphenyl thioaidenafil and aminotadalafil) have not been established, but they may be even more toxic than the original compounds.
HSA advises members of the public to stop taking these products immediately and seek medical attention if they feel unwell or experience any adverse effects.
Please refer to the following website in HSA for details:
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/../54644a-eng.php
In Hong Kong, the above products are not registered pharmaceutical products.
Ends/ Saturday, August 15, 2015
Issued at HKT 12:00
|
|
|